Qiangsheng Hu

2.1k total citations · 1 hit paper
40 papers, 1.5k citations indexed

About

Qiangsheng Hu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Qiangsheng Hu has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 17 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Qiangsheng Hu's work include Epigenetics and DNA Methylation (13 papers), Pancreatic and Hepatic Oncology Research (13 papers) and RNA modifications and cancer (8 papers). Qiangsheng Hu is often cited by papers focused on Epigenetics and DNA Methylation (13 papers), Pancreatic and Hepatic Oncology Research (13 papers) and RNA modifications and cancer (8 papers). Qiangsheng Hu collaborates with scholars based in China, United States and Australia. Qiangsheng Hu's co-authors include Yi Qin, Xianjun Yu, Wensheng Liu, Shunrong Ji, Wenyan Xu, Qiqing Sun, Xiaowu Xu, Zheng Zhang, Jin Xu and Guixiong Fan and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Qiangsheng Hu

39 papers receiving 1.5k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species

2025 31 citations Cong Jiang, Qiangsheng Hu et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qiangsheng Hu China	24	970	635	537	429	158	40	1.5k
Qin Dang China	19	911 0.9×	678 1.1×	442 0.8×	567 1.3×	255 1.6×	51	1.7k
Charlotte Kopitz Germany	19	981 1.0×	787 1.2×	639 1.2×	361 0.8×	141 0.9×	40	1.7k
Yitian Chen China	18	583 0.6×	424 0.7×	466 0.9×	223 0.5×	183 1.2×	45	1.3k
Zhiliang Lu China	23	1.1k 1.1×	788 1.2×	467 0.9×	368 0.9×	208 1.3×	38	1.6k
Eriko Katsuta United States	24	773 0.8×	501 0.8×	695 1.3×	403 0.9×	372 2.4×	82	1.6k
Siyuan Weng China	18	717 0.7×	442 0.7×	523 1.0×	530 1.2×	314 2.0×	75	1.5k
Yun Jung Choi South Korea	18	751 0.8×	372 0.6×	530 1.0×	349 0.8×	262 1.7×	45	1.4k
Uthra Balaji United States	14	683 0.7×	661 1.0×	1.1k 2.1×	271 0.6×	208 1.3×	24	1.6k
Zhihua Li China	23	919 0.9×	808 1.3×	738 1.4×	179 0.4×	254 1.6×	50	1.6k

Countries citing papers authored by Qiangsheng Hu

Since Specialization

Citations

This map shows the geographic impact of Qiangsheng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiangsheng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiangsheng Hu more than expected).

Fields of papers citing papers by Qiangsheng Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiangsheng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiangsheng Hu. The network helps show where Qiangsheng Hu may publish in the future.

Co-authorship network of co-authors of Qiangsheng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiangsheng Hu. A scholar is included among the top collaborators of Qiangsheng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiangsheng Hu. Qiangsheng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Qiangsheng, Yi Qin, Jingyi Wang, et al.. (2025). Pentose phosphate recycling driven by Gli1 contributes to chemotherapy resistance in cancer cells. Cancer Letters. 618. 217633–217633. 3 indexed citations

Jiang, Cong, Qiangsheng Hu, Shuqi Wang, et al.. (2025). Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species. Nature Communications. 16(1). 424–424. 31 indexed citations breakdown →

Zhang, Zheng, Huaxiang Xu, Junyi He, et al.. (2025). Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells. Cell Death and Disease. 16(1). 28–28. 6 indexed citations

Cheng, Lei, Qiangsheng Hu, Yanan Wang, et al.. (2024). Cis‐Regulation of an m⁶A Eraser by an Insertion Variant Associated with Survival of Patients With Non‐Small Cell Lung Carcinoma. Advanced Science. 12(5). e2407652–e2407652.

Hu, Qiangsheng, Jie Dai, Zheng Zhang, et al.. (2023). ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells. Cancer Research. 83(10). 1646–1665. 43 indexed citations

Hu, Qiangsheng, Tingcheng Li, Junheng Zhang, et al.. (2023). Ultrahigh Flowability and Excellent Mechanical Performance of Glass Fiber/PA6 Composites Prepared by Hyperbranched Polymers. Macromolecular Materials and Engineering. 308(8). 6 indexed citations

Hu, Qiangsheng, Yi Qin, Jin Xu, et al.. (2022). The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context. Frontiers in Oncology. 12. 862743–862743. 74 indexed citations

Hu, Qiangsheng, Yi Qin, Shunrong Ji, et al.. (2021). MTAP Deficiency–Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer. Cancer Research. 81(19). 4964–4980. 31 indexed citations

Zhang, Zheng, Yi Qin, Shunrong Ji, et al.. (2021). FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer. Acta Biochimica et Biophysica Sinica. 53(8). 997–1008. 14 indexed citations

10.

Liu, Mengqi, Qiangsheng Hu, Yi Qin, et al.. (2021). SETD8 induces stemness and epithelial–mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression. Acta Biochimica et Biophysica Sinica. 53(12). 1614–1624. 8 indexed citations

11.

Liu, Mengqi, Yi Qin, Qiangsheng Hu, et al.. (2020). SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. Cancer Letters. 499. 265–278. 22 indexed citations

12.

Zeng, Ye, Qifeng Zhuo, Qiangsheng Hu, et al.. (2020). FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. Redox Biology. 38. 101807–101807. 202 indexed citations

13.

Zeng, Ye, Wensheng Liu, Qifeng Zhuo, et al.. (2020). Ferroptosis: Final destination for cancer?. Cell Proliferation. 53(3). e12761–e12761. 93 indexed citations

14.

Zhang, Zheng, Mengqi Liu, Qiangsheng Hu, et al.. (2019). FGFBP1, a downstream target of the FBW7/c-Myc axis, promotes cell proliferation and migration in pancreatic cancer.. PubMed. 9(12). 2650–2664. 28 indexed citations

15.

Qin, Yi, Qiangsheng Hu, Jin Xu, et al.. (2019). PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis. Cell Communication and Signaling. 17(1). 30–30. 85 indexed citations

16.

Liu, Mengqi, Shunrong Ji, Wensheng Liu, et al.. (2019). Laparoscopic pancreaticoduodenectomy: are the best times coming?. World Journal of Surgical Oncology. 17(1). 81–81. 22 indexed citations

17.

Liang, Chen, Yi Qin, Bo Zhang, et al.. (2017). Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Research. 15(2). 201–212. 46 indexed citations

18.

Hu, Qiangsheng, Yi Qin, Bo Zhang, et al.. (2017). FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1. Oncology Reports. 38(4). 2069–2077. 26 indexed citations

19.

Liu, Wensheng, Bo Zhang, Qiangsheng Hu, et al.. (2017). A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism. International Journal of Oncology. 50(5). 1792–1800. 22 indexed citations

20.

Liang, Chen, Yi Qin, Bo Zhang, et al.. (2016). Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1866(2). 177–188. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact